Verona Pharma Stock Forward View
| VRNADelisted Stock | USD 86.00 2.00 2.38% |
Verona Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Verona Pharma stock prices and determine the direction of Verona Pharma PLC's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Verona Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time the value of rsi of Verona Pharma's share price is below 20 . This entails that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 13
Sell Peaked
Oversold | Overbought |
Using Verona Pharma hype-based prediction, you can estimate the value of Verona Pharma PLC from the perspective of Verona Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Verona Pharma PLC on the next trading day is expected to be 92.82 with a mean absolute deviation of 2.49 and the sum of the absolute errors of 151.76. Verona Pharma after-hype prediction price | USD 86.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Verona |
Verona Pharma Additional Predictive Modules
Most predictive techniques to examine Verona price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Verona using various technical indicators. When you analyze Verona charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Verona Pharma Naive Prediction Price Forecast For the 21st of February
Given 90 days horizon, the Naive Prediction forecasted value of Verona Pharma PLC on the next trading day is expected to be 92.82 with a mean absolute deviation of 2.49, mean absolute percentage error of 11.19, and the sum of the absolute errors of 151.76.Please note that although there have been many attempts to predict Verona Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Verona Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Verona Pharma Stock Forecast Pattern
| Backtest Verona Pharma | Verona Pharma Price Prediction | Research Analysis |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Verona Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Verona Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 120.5256 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 2.4878 |
| MAPE | Mean absolute percentage error | 0.0262 |
| SAE | Sum of the absolute errors | 151.757 |
Predictive Modules for Verona Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Verona Pharma PLC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Verona Pharma After-Hype Price Density Analysis
As far as predicting the price of Verona Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Verona Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Verona Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Verona Pharma Estimiated After-Hype Price Volatility
In the context of predicting Verona Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Verona Pharma's historical news coverage. Verona Pharma's after-hype downside and upside margins for the prediction period are 86.00 and 86.00, respectively. We have considered Verona Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Verona Pharma is very steady at this time. Analysis and calculation of next after-hype price of Verona Pharma PLC is based on 3 months time horizon.
Verona Pharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Verona Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Verona Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Verona Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 10 Events / Month | 2 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
86.00 | 86.00 | 0.00 |
|
Verona Pharma Hype Timeline
Verona Pharma PLC is at this time traded for 86.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Verona is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Verona Pharma is about 0.0%, with the expected price after the next announcement by competition of 86.00. About 92.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 1.04. Verona Pharma PLC had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 10 days. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.Verona Pharma Related Hype Analysis
Having access to credible news sources related to Verona Pharma's direct competition is more important than ever and may enhance your ability to predict Verona Pharma's future price movements. Getting to know how Verona Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Verona Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SGEN | Seagen Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BDX | Becton Dickinson and | 5.70 | 7 per month | 0.70 | 0.14 | 3.22 | (1.77) | 7.13 | |
| ALPN | Alpine Immune Sciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IMGN | ImmunoGen | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ONC | BeiGene | (3.71) | 8 per month | 0.00 | (0.06) | 4.12 | (2.78) | 8.26 | |
| RXDX | Prometheus Biosciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RETA | Reata Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ERYP | Erytech Pharma SA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KRTX | Karuna Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BPMC | Blueprint Medicines Corp | 0.03 | 7 per month | 0.61 | 0.18 | 5.43 | (1.91) | 26.28 |
Verona Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Verona Pharma stock to make a market-neutral strategy. Peer analysis of Verona Pharma could also be used in its relative valuation, which is a method of valuing Verona Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Verona Pharma Market Strength Events
Market strength indicators help investors to evaluate how Verona Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Verona Pharma shares will generate the highest return on investment. By undertsting and applying Verona Pharma stock market strength indicators, traders can identify Verona Pharma PLC entry and exit signals to maximize returns.
Verona Pharma Risk Indicators
The analysis of Verona Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Verona Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting verona stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.2 | |||
| Standard Deviation | 2.62 | |||
| Variance | 6.88 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Verona Pharma
The number of cover stories for Verona Pharma depends on current market conditions and Verona Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Verona Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Verona Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Verona Pharma Short Properties
Verona Pharma's future price predictability will typically decrease when Verona Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Verona Pharma PLC often depends not only on the future outlook of the potential Verona Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Verona Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 81.5 M | |
| Cash And Short Term Investments | 399.8 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Verona Stock
If you are still planning to invest in Verona Pharma PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Verona Pharma's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |